SCHEMBL7471087

SCHEMBL7471087

COC(=O)c1ccc2c(C(=O)C(C)C)c(C)n(Cc3ccccc3Cl)c2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.49
MAPT P10636 6/20 0.48
TP53 P04637 2/20 0.48
PLA2G2A P14555 3/20 0.47
S1PR3 Q99500 2/20 0.45
ALDH1A1 P00352 4/20 0.44
GAA P10253 2/20 0.44
LMNA P02545 2/20 0.44
PKM P14618 1/20 0.43
DPP4 P27487 1/20 0.43
KDM4E B2RXH2 2/20 0.43
HPGD P15428 1/20 0.43
PPARG P37231 2/20 0.42
MAPK1 P28482 2/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
USP14 P54578 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7421205 0.90 L3MBTL1 (0.62) L3MBTL1MAPTTP53PLA2G2AS1PR3
SCHEMBL7469713 0.89 L3MBTL1 (0.52) L3MBTL1MAPTTP53PLA2G2AALDH1A1
SCHEMBL7418990 0.88 MAPT (0.44) L3MBTL1MAPTTP53PLA2G2AS1PR3
SCHEMBL7468891 0.88 MAPT (0.44) L3MBTL1MAPTTP53PLA2G2AS1PR3
SCHEMBL7420991 0.88 L3MBTL1 (0.49) L3MBTL1MAPTTP53PLA2G2AS1PR3
SCHEMBL7422326 0.88 L3MBTL1 (0.51) L3MBTL1MAPTTP53PLA2G2AALDH1A1
SCHEMBL7415932 0.87 MAPT (0.43) L3MBTL1MAPTTP53PLA2G2AS1PR3
SCHEMBL7425401 0.86 MAPT (0.43) L3MBTL1MAPTTP53PLA2G2AS1PR3
SCHEMBL8557370 0.86 TP53 (0.43) L3MBTL1MAPTTP53PLA2G2AS1PR3
SCHEMBL7476760 0.85 MAPT (0.44) L3MBTL1MAPTTP53PLA2G2AS1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed